NCT00623883View on ClinicalTrials.gov

Colonoscopic Removal of Aberrant Crypt Foci: a Prospective, Randomized, Blinded Trial

NACompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Colorectal Neoplasms
Interventions
PROCEDURE

Surgical removal of ACF

All ACF removed by either cold or hot colonoscopic biopsy forceps

PROCEDURE

Colonoscopic evaluation only

Stain-enhanced magnification endoscopy performed, ACF quantified at entry and after one year

Trial Locations (1)

20889

National Naval Medical Center, Bethesda

All Listed Sponsors
collaborator

Uniformed Services University of the Health Sciences

FED

collaborator

National Cancer Institute (NCI)

NIH

lead

National Naval Medical Center

FED

NCT00623883 - Colonoscopic Removal of Aberrant Crypt Foci: a Prospective, Randomized, Blinded Trial | Biotech Hunter | Biotech Hunter